Article Information
History
- April 27, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alexandra Tompkins1,2,*,
- Zane N. Gray1,2,*,
- Rebekah E. Dadey1,2,
- Serafettin Zenkin1,3,
- Nasim Batavani1,3,
- Sarah Newman1,2,
- Afsaneh Amouzegar1,2,
- Murat Ak1,3,
- Nursima Ak1,3,
- Taha Yasin Pak1,3,
- Vishal Peddagangireddy1,3,
- Priyadarshini Mamindla1,3,
- Sarah Behr1,
- Amy Goodman1,
- Darcy L. Ploucha1,
- John M. Kirkwood1,2,
- Hassane M. Zarour1,4,
- Yana G. Najjar1,2,
- Diwakar Davar1,2,
- Rivka Colen1,3,
- Jason J. Luke1,2,# and
- Riyue Bao1,2,#
- 1UPMC Hillman Cancer Center, Pittsburgh, PA
- 2University of Pittsburgh, Department of Medicine, Pittsburgh, PA
- 3University of Pittsburgh Department of Radiology, Pittsburgh, PA
- 4University of Pittsburgh, Department of Immunology, Pittsburgh, PA
- ↵#Co-senior and corresponding authors. Corresponding Authors:, Jason J. Luke, MD, FACP Associate Professor of Medicine UPMC Hillman Cancer Center 5150 Centre Ave. Room 1.27C Pittsburgh, PA 15232, Telephone: (412) 647-2811, Fax: (412) 623-7948, lukejj{at}upmc.edu, Riyue Bao, PhD, Associate Professor of Medicine UPMC Hillman Cancer Center, 5150 Centre Ave, Suite 1A, Room 105 Pittsburgh, PA 15232, Telephone: (412) 623-0021, Fax: (412) 864-7603, baor{at}upmc.edu
↵* Equal Contribution.
Posted April 27, 2024.
Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma
